Evidence map›Paper›PMID 27013652›Full record

Trial reportHaematologica2016

Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI.

Megan Othus, Wim van Putten, Bob Lowenberg, Stephen H Petersdorf, Sucha Nand, Harry Erba, Frederick Appelbaum, Robert Hills, Nigel Russell, Alan Burnett and 1 more

Abstract readClinical TrialLetterMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Haematologica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Clinical endpoints in oncology - a primer.American journal of cancer research · 2021
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Megan OthusFred Hutchinson Cancer Research Center, Seattle, WA, USA mothus@fhcrc.org.
Wim van PuttenErasmus University Medical Center, Rotterdam, The Netherlands.
Bob LowenbergErasmus University Medical Center, Rotterdam, The Netherlands.
Stephen H PetersdorfUniversity of Washington and Seattle Cancer Care Alliance, Seattle, WA, USA.
Sucha NandLoyola University Medical Center, Maywood, IL, USA.
Harry ErbaDivision of Hematology & Oncology, Department of Medicine, University of Alabama, Birmingham, AL, USA.
Frederick AppelbaumFred Hutchinson Cancer Research Center, Seattle, WA, USA University of Washington, Seattle, WA, USA.
Robert HillsCardiff University School of Medicine, UK.
Nigel RussellUniversity Hospital National Health Service Trust, Nottingham, UK.
Alan BurnettCardiff University School of Medicine, UK.
Elihu EsteyFred Hutchinson Cancer Research Center, Seattle, WA, USA University of Washington, Seattle, WA, USA.

Funding

SWOG Network Group Operations Center of the NCTNU10CA180888 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PRIMO N. LARA · 2014 to 2026
$152.1M
SWOG Statistics & Data Management Center complex - extension supplement for GY06U10CA180819 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Catherine M. Tangen · 2014 to 2026
$115.2M
Hutchinson Center as Lead Academic Participating Site (U10)U10CA180828 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI APPELBAUM, FREDERICK · 2014 to 2018
$3.0M
NCTN Deep South Research ConsortiumU10CA180855 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BJORNSTI, MARY-ANN, FALKSON, CARLA I · 2014 to 2018
$2.6M
Prediction of Treatment-Related Mortality and Therapeutic Resistance in AMLR21CA182010 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OTHUS, MEGAN, WALTER, ROLAND BRUNO · 2014 to 2015
$430k
NCI NIH HHS R21 CA182010NCI NIH HHS U10 CA180819NCI NIH HHS U10 CA180828NCI NIH HHS U10 CA180855NCI NIH HHS U10 CA180888
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAgedAged, 80 and overDisease-Free SurvivalFemaleHumansLeukemia, Myeloid, AcuteMaleMiddle AgedSurvival Rateacute myeloid leukemiaendpointsurrogacy

Identifiers

PMID27013652
PMCPMC5004473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.